Dr. Dmitri Dozortsev
PhD, HCLD, EMB, Scientific Director and Director of Omni-Med Laboratories
Scientific Director
- Dr. Dozortsev currently serves as a president of the American College of Embryology.
- Dr. Dozortsev in Wayne Medicine.
- Dr. Dozortsev in Detroit News and on FOX 2 TV.
- Thank you letter from Harvard Medical School.
- Dr. Dozortsev’s research project is profiled in Nature, the number one scientific journal in the world.
At the heart of Advanced Fertility Center of Texas is exclusively using services of Omni-Med Labratories directed by Dr. Dmitri Dozortsev, who also serves as Scientific Director of AFCT. Our laboratories are accredited by College of American Pathologist (CAP) and the American College of Embryology and registered with the FDA.
Dr. Dozortsev graduated as a physician (MD) from the Pavlov’s Medical School in St. Petersburg, Russia. However, instead of going into medical practice, he enrolled into a PhD program focused on the early development of mammals. He received a PhD in Biomedicine with the Highest Honors from the State University of Ghent in Belgium. He received his post-doctoral training in the Reproductive Genetics Institute at Illinois Masonic Medical Center in Chicago, IL.
Dr. Dmitri Dozortsev is credited with the discovery of the mechanism of ICSI, which revolutionized infertility treatment and redefining role of progesterone in ovulation. Recently he was included into Wikipedia directory of American Embryologists.
Dr. Dozortsev is board certified as a High Complexity Laboratory Director in Embryology and Andrology (HCLD) by the American Board of Bioanalysis and as a Reproductive Embryologist (EMB) by the American College of Embryology.
His expertise encompasses 30 years in the field of human embryology. He has more than 40 publications and several issued and pending patents. His research in analyzing human gametes prior to fertilization was featured in the number-one scientific journal: Nature. The European Society of Human Reproduction and Embryology included his fixation technique for preimplantation genetic diagnosis in its Best PGD Practice Guidelines.
